AcroCyte at SLAS 2026
Events January 29,2026
SLAS 2026  International Conference & Exhibition is the flagship annual meeting of the Society for Laboratory Automation and Screening (SLAS), bringing together the global life sciences community to advance laboratory automation, screening technologies, data science, and translational research. The conference will take place February 7–11, 2026 in Boston, Massachusetts, USA.

Visit AcroCyte at Booth #2543. We will showcase R3CE® (Rapid, Reproducible, Rare Cell 3D Expansion), our proprietary scaffold-free 3D culture platform designed for consistent, scalable spheroid and organoid formation without artificial matrices. R3CE® enables reproducible 3D models that integrate with high-content imaging and automated workflows, supporting disease modeling and drug response studies.

Event Information
▸ Date｜February 9–11, 2026
▸ Venue｜Thomas Michael Menino Convention & Exhibition Center (MCEC)｜Boston, MA, USA
▸ Booth｜#2543





🧾 Poster Presentations Featuring AcroCyte

Presentation Title: A Scaffold-free 3D Culture Platform for Paired Normal and Tumor Organoid Generation and Multimodal Validation from Colorectal Cancer Patient Specimens
Presentation Date: Monday, February 9, 2026
Track Name: Cellular Technologies
Session Title: Poster Presentations – Session B
Session Time: 2:00 PM – 3:00 PM
Poster No.: 1146-B
Room: Exhibit Halls AB

This study demonstrates how AcroCyte’s scaffold-free 3D platform enables the generation of paired normal and tumor organoids from patient-derived colorectal cancer specimens, supporting physiologically relevant modeling and multimodal validation approaches.


Presentation Title (Joint poster with Revvity): Longitudinal High-Content Imaging Workflow for 3D Spheroid Growth and Drug Responses on the Scaffold-Free R3CE® Platform Using the Opera Phenix™ and Celigo™ Imaging Systems
Presentation Date: Tuesday, February 10, 2026
Track Name: Assay Development and Screening
Session Title: Poster Presentations – Session C
Session Time: 12:00 PM – 1:00 PM
Poster No.: 1347-C
Room: Exhibit Halls AB

This work presents an integrated workflow combining the R3CE® platform with high-content imaging systems to enable longitudinal monitoring of 3D spheroid growth dynamics and drug response profiling.


Presentation Title: R3CE®: A Scaffold-Free Culture Platform for Scalable, Progenitor-Like 3D Spheroid Formation
Presentation Date: Wednesday, February 11, 2026
Track Name: Cellular Technologies
Session Title: Poster Presentations – Session E
Session Time: 12:00 PM – 1:00 PM
Poster No.: 1384-E
Room: Exhibit Halls AB

This poster highlights R3CE® as a scalable platform for generating progenitor-like 3D spheroids with high reproducibility, supporting next-generation cellular assays and screening applications.
Back
Privacy Preference Center

1. Who We Are
At AcroCyte Therapeutics Inc. (“AcroCyte”, “we”, “our”), we are committed to maintaining the trust and confidence of all visitors to our website, www.acrocyte.com. We value your privacy and want you to be clear about how we handle your data. In particular, AcroCyte is not in the business of selling, renting, or trading email lists with other companies for marketing purposes. This Privacy Policy outlines when and why we collect personal information, how we use it, the limited conditions under which we may disclose it to others, and how we keep it secure.

2. Information We Collect & How We Use It
Contact Forms & Business Inquiries
When you contact us via the forms on our website (such as the "Contact Us" page), we collect the professional information you provide, including your name, email address, phone number, company name, job title, industry, area of interest, and the content of your inquiry.

  • Purpose: We use this data solely to communicate with you, verify your identity, answer your technical or business questions, and provide information about our products and services relevant to your request.
  • Marketing Communications: We will only send you newsletters, product updates, or promotional materials if you have explicitly opted in by checking the relevant box (e.g., "Yes, I'd like to receive updates about AcroCyte news and breakthroughs"). You may unsubscribe from these communications at any time by clicking the "unsubscribe" link in our emails.

Cookies
We use cookies to support essential website functionality and to provide a better user experience. You can choose to disable or delete cookies at any time through your internet browser settings; however, this may limit your ability to use certain features of our website.

3. Third-Party Services & Data Processors

Google Analytics
We use Google Analytics to collect standard internet log information and details of visitor behavior patterns. This helps us understand website traffic and improve performance. This information is processed in a way that does not identify anyone personally. We do not make, and do not allow Google to make, any attempt to find out the identities of those visiting our website.

Google reCAPTCHA
To protect our website forms from spam and automated abuse, we use the reCAPTCHA service provided by Google. This service analyzes behavior to distinguish between humans and bots. Your use of reCAPTCHA is subject to Google’s Privacy Policy and Terms of Service.

Service Providers
We may share your information with trusted third-party service providers who assist us in operating our website, conducting our business, or serving our users (e.g., email delivery services, CRM systems, or hosting providers), so long as those parties agree to keep this information confidential.

4. International Data Transfers
AcroCyte operates globally with offices in Taiwan and the United States. Please be aware that your personal information may be transferred to, stored, and processed in a country other than the one in which you reside. By providing us with your information, you acknowledge and agree to this transfer, storage, or processing. We take all reasonable steps to ensure that your data is treated securely and in accordance with this policy.

5. Data Retention
We retain your personal information only for as long as is necessary to fulfill the purposes for which it was collected, including for the purposes of satisfying any legal, accounting, or reporting requirements. When data is no longer needed, we will securely delete or anonymize it.

6. Access to Your Personal Information & Your Rights
You have the right to request access to, correction of, or deletion of any personal data that we hold about you. Depending on your jurisdiction (such as under the GDPR), you may also have the right to restrict processing, object to processing, or request data portability. To make such a request, please contact our Privacy Team at [info@acrocyte.com].

7. Changes to Our Privacy Policy
We may update this Privacy Policy from time to time to reflect changes in our practices or for other operational, legal, or regulatory reasons. The most current version will always be available on our website. By continuing to access or use our website after those changes become effective, you agree to be bound by the revised Privacy Policy.

Cookie Notice